TORONTO, ONTARIO / ACCESS Newswire / October 24, 2025 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE: D4G)(OTC:DTMXF) is pleased to announce the appointment of Mr. Enrico Moretti, a securities lawyer at Irwin Lowy LLP, as a member of the Board of Directors, effective immediately.

This new addition fulfills the minimum number of directors requirement under Exchange policies. Mr. Moretti who specializes in corporate and securities law, providing guidance to companies, investment bankers, and investment funds on corporate finance transactions, including public and private offerings, reverse takeovers, qualifying transactions, as well as corporate governance and regulatory compliance matters. Mr. Moretti was called to the bar in Ohio, USA in 1997, and in Ontario, Canada in 2000, bringing extensive cross-border legal expertise to the Company's Board.

The Company has been advised that the Exchange will impose a trading halt while the Company ensures it meets the minimum director requirement. Upon becoming aware of this matter, the Company acted promptly to rectify the situation with Mr. Moretti's appointment and is in active communication with the Exchange to address the deficiency. The Company is working diligently to rectify any trading disruption and to confirm compliance with the Exchange's listing requirements as soon as possible.

Paul Haber, CEO of Datametrex, commented, "We are pleased to welcome Mr. Enrico Moretti to the Board. His deep expertise in securities law and corporate governance, combined with his cross-border experience, will be an asset to the Company as we continue to strengthen our governance and compliance framework".

About Datametrex

Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.

For more on Datametrex, please visit our Company website.

For Additional Information

Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

Forward-Looking Statements

This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.

While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.

Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.

This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.

###

SOURCE: DataMetrex AI Ltd.